000 01698nam a22003497a 4500
008 190823s20192019 xxu||||| |||| 00| 0 eng d
022 _a2054-4774
024 _a10.1136/bmjgast-2019-000284 [doi]
024 _abmjgast-2019-000284 [pii]
024 _aPMC6626471 [pmc]
040 _aOvid MEDLINE(R)
099 _a31354958
245 _aPseudoachalasia secondary to metastatic bladder cancer.
251 _aBMJ Open Gastroenterology. 6(1):e000284, 2019.
252 _aBMJ Open Gastroenterol. 6(1):e000284, 2019.
253 _aBMJ open gastroenterology
260 _c2019
260 _fFY2020
265 _sepublish
266 _d2019-08-23
520 _aPseudoachalasia, or secondary achalasia, is a clinical condition that must be distinguished from primary achalasia. Both diagnoses may present similarly, but the aetiology and management for each are drastically different. Most significantly, pseudoachalasia carries a high association with malignancy, most often with primary adenocarcinoma of the oesophagus or cardia. Our case involves a patient with signs and symptoms consistent with pseudoachalasia due to metastatic bladder cancer.
546 _aEnglish
650 _aIN PROCESS -- NOT YET INDEXED
651 _aMedStar Washington Hospital Center
656 _aMedStar Georgetown University Hospital Residents
657 _aCase Reports
700 _aHaberstroh, William
790 _aHaberstroh W, Shafa S
856 _uhttps://dx.doi.org/10.1136/bmjgast-2019-000284
_zhttps://dx.doi.org/10.1136/bmjgast-2019-000284
858 _yHaberstroh, William
_uhttps://orcid.org/0000-0003-2801-9160
_zhttps://orcid.org/0000-0003-2801-9160
942 _cART
_dArticle
999 _c11287
_d11287